Clinical Trial Update: A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Hepatic Impairment Patients and Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 study comparing pharmacokinetics and safety of fimasartan in individuals with hepatic impairment to healthy volunteers in the setting of essential hyp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension
• Hepatic Impairment

Drugs mentioned

• Fimasartan (fimasartan)

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Essential Hypertension, Hepatic Impairment | Phase 1 | Status: COMPLETED